Nuclear IncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer
Ovarian cancer(OC)is the most lethal type of cancer among female genital tumors.1 Along with debulking sur-geries,platinum is the first-line chemotherapy treatment,whereas chemoresistance is the biggest obstacles in a poor prognosis of OC.2 Identifying a novel therapeutic target for OC chemoresistance remains an urgent need.
apoptosis、cisplatin、incrna、cancer、cell、activation、cerna1、chemoresistance、enhances、epigenetic
10
R733.7;R392.12;R285.5
2023-05-26(万方平台首次上网日期,不代表论文的发表时间)
共4页
10-13